<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287972</url>
  </required_header>
  <id_info>
    <org_study_id>ORL-CHIR-003</org_study_id>
    <nct_id>NCT04287972</nct_id>
  </id_info>
  <brief_title>A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients</brief_title>
  <official_title>A Monocentric Randomized Controlled Prospective Study to Evaluate the Antireflux Efficacy of Primary Crural Closure During Sleeve Gastrectomy for Obese Patients With Incompetents Oeso-gastric Valves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fabio Garofalo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ente Ospedaliero Cantonale, Bellinzona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a monocentric randomized controlled prospective study. A total of 122 patients will
      be recruited and randomized 1: 1 in the experimental group - Laparoscopic Sleeve Gastrectomy
      and Diaphragmatic Pillar Closure - or in the control group - Laparoscopic Sleeve Gastrectomy.

      At 6 months post surgery a gastroscopy, an oesophageal manometry and a PH-study will be
      perform to detect de novo GastroEsophageal Reflux Disease and hiatal hernia appearance.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>De novo GastroEsophageal Reflux Disease (GERD) onset</measure>
    <time_frame>6 months post surgery</time_frame>
    <description>At 6 months post surgery a gastroscopy, an oesophageal manometry and a PH-study will be perform to detect de novo GERD (GastroEsophageal Reflux Disease)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hiatal hernia appearance</measure>
    <time_frame>6 months post surgery</time_frame>
    <description>At 6 months post surgery a gastroscopy, an oesophageal manometry and a PH-study will be perform to detect hiatal hernia appearance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in patient-reported quality of life using Gastroparesis Cardinal Symptom Index (GCSI) questionnaire</measure>
    <time_frame>baseline and 6 months post surgery</time_frame>
    <description>Evaluation of benefits in term of life quality by Gastroparesis Cardinal Symptom Index (GCSI) self-assessment of gastroparesis symptoms.
The Gastroparesis Cardinal Symptom Index (GCSI), is a questionnaire that assess severity of symptoms associated with gastroparesis. Symptoms are rated from 0 (no symptom) to 5 (very severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in patient-reported quality of life using GERD-Health Related Quality of Life Questionnaire (GERD-HRQL) questionnaire</measure>
    <time_frame>baseline and 6 months post surgery</time_frame>
    <description>Evaluation of benefits in term of life quality and reduction of Protonic Pomp Inhibitors drugs by GERD-Health Related Quality of Life questionnaire.
Questionnaire (GERD-HRQL) for symptoms related to GERD. Symptoms are rated from 0 (no symptom) to 5 (Symptoms are incapacitating to do daily activities). The total Score is calculated by summing the individual scores to 15 questions.
Greatest possible score (worst symptoms) = 75
Lowest possible score (no symptoms) = 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</measure>
    <time_frame>6 months post surgery</time_frame>
    <description>Evaluation of number of participants with treatment-related adverse events ( short and long term surgical complications)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">122</enrollment>
  <condition>Gastroesophageal Reflux</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>LSG-DPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Sleeve Gastrectomy and Diaphragmatic Pillar Closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic Sleeve Gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DPC</intervention_name>
    <description>The anterior fat pad is dissected until the left crura is visible, pars flaccida is open and the right crura exposed. Phreno-oesophageal ligament is sectioned starting from the right crura. Posterior and anterior vagal nerve are recognized before the oesophageal dissection. An intra-abdominal oesophagus lengths of 2 or 3 cm is obtained in order to reduce tension. Left and right crura are sutured with 2 or 3 non absorbable 2-0 stitches; an additional anterior stitch is posed if necessary to calibrate hiatus size without oesophageal deviation.</description>
    <arm_group_label>LSG-DPC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LSG</intervention_name>
    <description>After omental section close to gastric insertion, gastric stapling is realised with triple line endo stapler (normally 5 or 6 re-loads). The gastrectomy begins 5-6 cm from the pylorus; gastric fundus is totally resected keeping a distance of 5-10 mm from oesophagus. Any bleeding on staple line is controlled with surgical clips or coagulator.</description>
    <arm_group_label>LSG</arm_group_label>
    <arm_group_label>LSG-DPC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18-65 years

          -  Patient with BMI between 35 and 50 Kg/m2 for whom laparoscopic sleeve gastrectomy
             indication was made

          -  Patients with no preoperative gastroesophageal reflux disease symptoms

          -  Hill 2-3 or 4 (with HH &lt;2 cm) hypogastric valve diagnosed preoperatively

        Exclusion Criteria:

          -  Gastroesophageal reflux disease with daily symptoms or daily use of proton pump
             inhibitors drugs or daily use of anti-H2 drugs

          -  Hiatal Hernia &gt;2cm and/or esophagitis and/or Barrett metaplasia

          -  Previous bariatric and/or gastric surgery

          -  Normal gastroesophageal valve (Hill 1)

          -  Motility disorders of the esophagus (documented on manometry)

          -  PH-study positive for gastro-oesophageal reflux disease (DeMeester Score &gt;14.1)

          -  Contraindications to gastroscopy or manometry or ph-study

          -  Inability to follow the procedures of the study, e.g. due to language problems,
             psychological disorders, dementia, etc. of the participant

          -  Patient not legally competent

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabio Garofalo</last_name>
    <role>Principal Investigator</role>
    <affiliation>EOC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabio Garofalo, MD</last_name>
    <phone>+41 (0)91 811 68 24</phone>
    <email>Fabio.Garofalo@eoc.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Regionale di Lugano, Civico e Italiano</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Garofalo, MD</last_name>
      <phone>+41 (0)91 811 68 24</phone>
      <email>Fabio.Garofalo@eoc.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 21, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ente Ospedaliero Cantonale, Bellinzona</investigator_affiliation>
    <investigator_full_name>Fabio Garofalo</investigator_full_name>
    <investigator_title>Sponsor Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

